oral, brain-penetrant O-GlcNAcase (OGA) inh.

structurally distinct in vivo tool

from virtual screen of 100k cmpd, testing 2681

J. Med. Chem., Jan. 6, 2021

Takeda Pharmaceutical, Fujisawa, JP

Chemical structure of compound-5i Takeda O-GlcNAcase (OGA) inhibitor

The Takeda O-GlcNAcase (OGA) inhibitor, “compound 5i,” binds to the same site as prior sugar-based OGA inhibitors, but has surprisingly different chemical properties and a unique binding mode. The…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: